Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ABAX --- lots of upside -- Ignore unavailable to you. Want to Upgrade?

To: Yo Yo who wrote (484)	3/16/1999 11:34:00 AM
From: David Bogdanoff	Read Replies (3) \| Respond to of 492

YY; Thanks for the update on this company. I looked at it a couple of years ago and determined that it looked maily or exclusively at gases; apparently it has added a couple of tests since then but it is nowhere near a comlete blood chemistry which is what hospitals routinely do in volume. So I don't see it as a competitor to ABAX. If anything, it only serves to show the difficulties in breaking into the hospital market. I note that ABAX is doing much better in the vet market and other niche markets such as the military or Mexico. David